Literature DB >> 25119590

Molecular regulation of ovarian cancer cell invasion.

Ningxia Sun1, Qing Zhang, Chen Xu, Qian Zhao, Yan Ma, Xinmei Lu, Liang Wang, Wen Li.   

Abstract

The molecular mechanism underlying ovarian cancer invasiveness and metastasis remains unclear. Since significant downregulation in microRNA 200 (miRNA200) family (miR200a, miR200b, and miR200c) has been reported in the invasive ovarian cancer cells, here, we used two human ovarian cancer cell lines, OVCAR3 and SKOV3, to study the molecular basis of miR200, matrix metalloproteinase 3 (MMP3) activation, and cancer invasiveness. We found that overexpression of either miR200 family member in OVCAR3 or SKOV3 cells significantly inhibited production and secretion of MMP3 and cancer invasiveness. Moreover, forced MMP3 expression abolished miR200-induced inhibition of ovarian cancer cell invasiveness, suggesting that miR200 family inhibited ovarian cell invasiveness via downregulating MMP3. Furthermore, ZEB1, a major target of miR200, was inhibited by miR200 overexpression. Forced ZEB1 expression abolished miR200-induced inhibition of ovarian cancer cell invasiveness, suggesting that ZEB1 is a direct target of miR200 for inhibiting ovarian cell invasiveness. Finally, phosphorylated SMAD3 (pSMAD3), a major partner of ZEB1, was efficiently inhibited by miR200, which could be restored by forced expression of ZEB1, but not by forced expression of MMP3, suggesting that ZEB1/pSMAD3 is signaling cascade upstream of MMP3 in this model. Taken together, our data suggest that miR200 family inhibited ovarian cancer cell invasiveness and metastasis by downregulating MMP3, possibly through ZEB1/pSMAD3.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119590     DOI: 10.1007/s13277-014-2434-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

Review 1.  siRNA and miRNA for the treatment of cancer.

Authors:  R Jankovic; S Radulovic; M Brankovic-Magic
Journal:  J BUON       Date:  2009-09       Impact factor: 2.533

2.  The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.

Authors:  Susanna Leskelä; Luis J Leandro-García; Marta Mendiola; Jorge Barriuso; Lucía Inglada-Pérez; Iván Muñoz; Beatriz Martínez-Delgado; Andrés Redondo; Javier de Santiago; Mercedes Robledo; David Hardisson; Cristina Rodríguez-Antona
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

3.  The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.

Authors:  K Szyllo; B Smolarz; H Romanowicz-Makowska; M Niewiadomski; E Kozlowska; A Kulig
Journal:  J Exp Clin Cancer Res       Date:  2002-09

4.  Smad3 regulates E-cadherin via miRNA-200 pathway.

Authors:  S-M Ahn; J-Y Cha; J Kim; D Kim; H T H Trang; Y-M Kim; Y-H Cho; D Park; S Hong
Journal:  Oncogene       Date:  2011-10-24       Impact factor: 9.867

5.  Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma.

Authors:  S Nakahata; S Yamazaki; H Nakauchi; K Morishita
Journal:  Oncogene       Date:  2010-05-31       Impact factor: 9.867

Review 6.  Roles of TGFbeta in metastasis.

Authors:  David Padua; Joan Massagué
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

7.  Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway.

Authors:  Antonio A Postigo
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

8.  PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.

Authors:  Beata Smolarz; Krzysztof Szyłło; Hanna Romanowicz-Makowska; Mariusz Niewiadomski; Elzbieta Kozłowska; Andrzej Kulig
Journal:  Pol J Pathol       Date:  2003       Impact factor: 1.072

Review 9.  MiR-200, a new star miRNA in human cancer.

Authors:  Xiangling Feng; Zhengming Wang; Rebecca Fillmore; Yaguang Xi
Journal:  Cancer Lett       Date:  2013-11-19       Impact factor: 8.679

10.  Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200.

Authors:  Miharu Kobayashi; Carlos Salomon; Jorge Tapia; Sebastian E Illanes; Murray D Mitchell; Gregory E Rice
Journal:  J Transl Med       Date:  2014-01-06       Impact factor: 5.531

View more
  11 in total

Review 1.  Ovarian cancer: involvement of the matrix metalloproteinases.

Authors:  Linah Al-Alem; Thomas E Curry
Journal:  Reproduction       Date:  2015-04-27       Impact factor: 3.906

2.  RhoGDIβ promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation.

Authors:  Haishan Huang; Honglei Jin; Huirong Zhao; Jingjing Wang; Xin Li; Huiying Yan; Shuai Wang; Xirui Guo; Lei Xue; Jingxia Li; Minggang Peng; Annette Wang; Junlan Zhu; Xue-Ru Wu; Changyan Chen; Chuanshu Huang
Journal:  Mol Oncol       Date:  2017-09-11       Impact factor: 6.603

3.  Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

Authors:  Paola Tiberio; Ludmila Lozneanu; Valentina Angeloni; Elena Cavadini; Patrizia Pinciroli; Maurizio Callari; Maria Luisa Carcangiu; Domenica Lorusso; Francesco Raspagliesi; Valentina Pala; Maria Grazia Daidone; Valentina Appierto
Journal:  Oncotarget       Date:  2017-04-04

4.  Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.

Authors:  Yu Wang; Wenyu Guo; Zhaoqing Li; Yansheng Wu; Chao Jing; Yu Ren; Minghui Zhao; Lingping Kong; Chao Zhang; Jiabin Dong; Yu Shuang; Shanshan Sun; Jinliang Chen; Chuanqiang Wu; Yu Qiao; Xin Qu; Xudong Wang; Lun Zhang; Rui Jin; Xuan Zhou
Journal:  Int J Oncol       Date:  2018-02-28       Impact factor: 5.650

5.  α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis.

Authors:  Sandra Atlante; Alessia Visintin; Elisabetta Marini; Matteo Savoia; Chiara Dianzani; Marta Giorgis; Duran Sürün; Federica Maione; Frank Schnütgen; Antonella Farsetti; Andreas M Zeiher; Massimo Bertinaria; Enrico Giraudo; Francesco Spallotta; Chiara Cencioni; Carlo Gaetano
Journal:  Cell Death Dis       Date:  2018-07-09       Impact factor: 8.469

6.  Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer.

Authors:  Honglei Jin; Lei Xue; Lan Mo; Dongyun Zhang; Xirui Guo; Jiheng Xu; Jingxia Li; Minggang Peng; Xuewei Zhao; Minghao Zhong; Dazhong Xu; Xue-Ru Wu; Haishan Huang; Chuanshu Huang
Journal:  Cell Adh Migr       Date:  2019-12       Impact factor: 3.405

Review 7.  miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition.

Authors:  Siti A Sulaiman; Nurul-Syakima Ab Mutalib; Rahman Jamal
Journal:  Front Pharmacol       Date:  2016-08-23       Impact factor: 5.810

Review 8.  MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer.

Authors:  Manish K Pal; Shyam P Jaiswar; Vinaya N Dwivedi; Amit K Tripathi; Ashish Dwivedi; Pushplata Sankhwar
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

9.  Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe.

Authors:  Kuo-Hwa Wang; Yun-Ming Wang; Li-Hsuan Chiu; Tze-Chien Chen; Yu-Hui Tsai; Chun S Zuo; Kuan-Chou Chen; Chun Austin Changou; Wen-Fu T Lai
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

Review 10.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.